Banka BioLoo Limited returned to profitability in FY26, reporting a net profit of ₹38.21 lakh compared to a loss of ₹929.64 lakh in the previous year. The company achieved this turnaround through an 8.6% increase in revenue to ₹6,101.18 lakh and a significant improvement in operational efficiency. The strong performance was led by a robust Q4, where revenue grew 28% year-on-year to ₹1,802.28 lakh, and net profit reached ₹157.06 lakh.

The company’s EBITDA swung to a positive ₹407.9 lakh for the full year, a marked recovery from a loss of ₹487.9 lakh in FY25. This improvement was driven by cost optimization and higher execution in the Water, Sanitation & Hygiene (WaSH) segment. Earnings per share (EPS) recovered to ₹0.35 for the year, compared to a loss of ₹8.57 per share in the prior year.

Financial Performance

The standalone financial results for Q4 and FY26 highlight a decisive recovery in the company's bottom line. The following table details the key financial metrics:

Order Book and Business Segments

Banka BioLoo’s total unexecuted order book stands at ₹107 crore, with a 12-month order book of ₹82 crore. The WaSH segment contributed significantly, securing new orders worth approximately ₹16 crore in Q4 FY26, bringing the 12-month total WaSH order booking to ₹56 crore. The company expanded its footprint into Bangalore and Mumbai with projects from Brigade, Reliance, and RMZ.

The Railways segment did not receive new orders in Q4 FY26, but the total unexecuted orders for the business stand at approximately ₹38 crore year-to-date. The 12-month Railways order booking was approximately ₹26 crore. The company maintains a presence across 7 Indian Railways zones and 26 states, with over 25,000 bio toilets installed and 25,000 systems under daily operation and maintenance.

Consolidated Results

On a consolidated basis, the company reported a net profit of ₹39.31 lakh for FY26, recovering from a loss of ₹890.87 lakh in the previous year. Total income for the year stood at ₹5,838.61 lakh, an increase of 7.1% year-on-year. Consolidated EBITDA turned positive at ₹622.49 lakh, compared to a loss of ₹283.19 lakh in FY25, reflecting the company’s improved operational leverage across its business verticals.

Banka BioLoo Limited has authorized its Key Managerial Personnel (KMPs) to determine the materiality of events and make disclosures to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This authorization, effective 26 May 2026, follows a change in personnel including the appointment of a new Company Secretary and Compliance Officer.

The Board of Directors has authorized Mr. Vishal Murarka, Chief Executive Officer and Executive Director, and Mr. Lakkimsetty Venkata Naga Padmanabham, Chief Financial Officer, for these purposes. Additionally, Ms. Srilakshmi Manjula Chaitanya Chunduru has been authorized as the Company Secretary and Compliance Officer following her recent appointment.

The company submitted the details to the National Stock Exchange of India Limited to update its records. The communication outlined the specific designations and contact details for the authorized personnel responsible for regulatory compliance and disclosures.

Authorized Key Managerial Personnel

The following table details the KMPs authorized for determining materiality and making disclosures:

The corporate address for the personnel is listed as the 5th floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016.